Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors.
Miederer, Matthias
Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2008 - 3555-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1078-0432
10.1158/1078-0432.CCR-07-4647 doi
Alpha Particles
Animals
Mice
Mice, Nude
Neoplasms, Experimental--radiotherapy
Neuroendocrine Tumors--radiotherapy
Octreotide--analogs & derivatives
Radioisotopes--therapeutic use
Radiopharmaceuticals--therapeutic use
Rats
Receptors, Somatostatin--radiation effects
Xenograft Model Antitumor Assays
Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2008 - 3555-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1078-0432
10.1158/1078-0432.CCR-07-4647 doi
Alpha Particles
Animals
Mice
Mice, Nude
Neoplasms, Experimental--radiotherapy
Neuroendocrine Tumors--radiotherapy
Octreotide--analogs & derivatives
Radioisotopes--therapeutic use
Radiopharmaceuticals--therapeutic use
Rats
Receptors, Somatostatin--radiation effects
Xenograft Model Antitumor Assays